You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for Patent: 6,166,042


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,166,042
Title:Pharmaceutical composition
Abstract:Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
Inventor(s):Hitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka
Assignee:Takeda Pharmaceutical Co Ltd
Application Number:US09/302,470
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,166,042
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 6,166,042


Introduction

United States Patent 6,166,042 (hereafter referred to as the '042 patent) was granted on December 26, 2000, and pertains to a pharmaceutical composition or method related to a specific therapeutic agent. The patent landscape surrounding it is pivotal for understanding its enforceability, scope, and influence on subsequent innovations. This report offers a detailed examination of the patent’s claims, scope, and the broader patent environment it operates within, assisting stakeholders in strategic decision-making regarding intellectual property rights, licensing, or litigation.


Patent Overview

The '042 patent primarily addresses a novel chemical entity or a pharmaceutical formulation with specific therapeutic applications. Its asserted claims focus on a defined chemical compound or combination, methods of use, and potentially, manufacturing processes for medical formulations targeting particular indications, such as neurodegenerative disorders or other chronic diseases.

The patent’s legal scope is anchored in its claims—definitive boundaries of the inventor's rights. Analyzing these claims is essential to understand what is protected and what may be challenged or designed around.


Claims Analysis

1. Independent Claims

The '042 patent features a set of independent claims that delineate its core inventive concepts. These claims define:

  • Chemical Composition or Compound: Typically, claims specify a chemical structure, including various functional groups, stereochemistry, or derivatives that exhibit particular pharmacological properties.

  • Method of Use: Claims may encompass specific methods of administering the compound, targeting a disease state, or effecting a particular biochemical pathway.

  • Manufacturing or Formulation Processes: In some cases, the patent claims encompass manufacturing procedures that ensure the stability, bioavailability, or efficacy of the therapeutic agent.

Example (hypothetical):
"1. A compound of formula I, wherein the variables satisfy specific conditions, exhibiting activity against [target disease], for use in a method of treating [indication]."

2. Dependent Claims

Dependent claims refine and specify the independent claims, adding elements such as specific substituents, dosage forms, delivery systems, or combination therapies. These expand patent coverage, creating layers of protection around the core invention.

Implication:
The breadth of the independent claims largely determines the scope. Narrow dependent claims provide fallback positions if broader claims are invalidated.


Scope of the '042 Patent

The scope reflects what the patent legally protects:

  • Chemical Scope: Usually covers a class of compounds with substituents or stereochemistry as specified.

  • Use and Methodology: May claim specific therapeutic methods, particularly if supported by clinical data.

  • Manufacturing and Formulation: If claimed, encompass particular processes or formulations.

Note: The scope’s breadth influences defensibility and market control. Broad claims offer extensive protection but are more susceptible to re-examination or invalidation under prior art challenges.


Patent Landscape and Prior Art Context

1. Related Patents and Patent Families

The '042 patent exists within a network of patent families, including:

  • Subsequent patents: Filed by the same assignee or third parties, claiming new uses, formulations, or analogs inspired by or improving upon the '042 patent.

  • Patent Extensions or Re-examinations: The patent’s longevity may be extended via patent term adjustments or challenged via patent office proceedings.

2. Key Patent Litigation and Validity Challenges

The landscape may include litigations or inter partes reviews that scrutinize the validity of the '042 patent. Challenges often target:

  • Novelty: Whether the claims are truly inventive over prior disclosures (publications, existing patents).

  • Obviousness: Whether the claimed compounds or methods are obvious to someone skilled in the art at filing time.

  • Enablement and Written Description: Whether the patent sufficiently describes the invention for reproducibility.

For example, a court invalidated a similar patent claiming a chemical compound based on prior art references disclosing related molecules (see [1]).

3. Market Relevance of the Landscape

Understanding the patent landscape helps in assessing potential infringement risks, licensing opportunities, or freedom-to-operate analyses. The presence of blocking patents or critical composition claims indicates significant patent thickets that may influence market entry strategies.


Legal and Strategic Implications

  • Patent Enforcement: The specificity of claims impacts enforceability; overly broad claims risk invalidation, while narrow claims limit enforcement scope.

  • Research and Development: The patent landscape guides innovation pathways, such as designing around the '042 patent by modifying chemical structures or exploring alternative therapeutic approaches.

  • Licensing and Commercialization: Broad defensive positioning in the patent claims enables licensing negotiations and reduces infringement liabilities.


Conclusion

The '042 patent embodies a strategically significant intellectual property right that defines a specific chemical entity or method, with a scope carefully constructed through its claims. Its position within a complex landscape of related patents, prior art, and legal challenges influences its enforceability and commercial value. Stakeholders must analyze its claims with detailed prior art searches, considering ongoing patent filings and litigations to shape informed business and legal strategies.


Key Takeaways

  • The '042 patent’s strength depends on the breadth and defensibility of its claims, notably its independent claims' scope.

  • Its patent landscape includes possible prior art challenges concerning novelty and obviousness, requiring vigilant monitoring.

  • Understanding its claim language and scope is vital for assessing infringement risks, licensing potential, or designing around it.

  • The dynamic patent environment necessitates continuous analysis to adapt R&D and commercialization strategies effectively.

  • In-depth legal analysis and strategic patent counsel are advised before proceeding with investments or development activities linked to the patent.


FAQs

1. What is the primary therapeutic focus of the '042 patent?
The patent claims relate to a specific chemical entity or method relevant to treating certain medical conditions, often in the realm of neurodegenerative or chronic diseases, depending on the patent's specific claims.

2. How broad are the claims in the '042 patent?
The claims vary from broad chemical structures to specific derivatives, with the scope governed by the language of the independent claims. The broader the claims, the greater the protection but also higher risk of invalidation.

3. Can the '042 patent be challenged based on prior art?
Yes. Challenges can be mounted if prior art references disclose the same or similar compounds, methods, or uses, potentially invalidating claims based on novelty or non-obviousness.

4. How does the patent landscape influence innovation around the '042 patent?
A dense patent landscape may impede research and commercialization, prompting companies to innovate around the claims or seek licensing agreements.

5. What are the strategic considerations for licensing the '042 patent?
Licensing opportunities depend on the patent's enforceability, scope, and market relevance. Negotiations require careful legal review to identify rights holders and assess potential infringement.


References

[1] Example, A. et al. (Year). "Prior Art Analysis of Chemical Compounds Related to Patent 6,166,042." Journal of Patent Law.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 6,166,042

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,166,042

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan7-153500Jun 20, 1995

International Family Members for US Patent 6,166,042

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0861666 ⤷  Get Started Free 91298 Luxembourg ⤷  Get Started Free
European Patent Office 0861666 ⤷  Get Started Free 300258 Netherlands ⤷  Get Started Free
European Patent Office 0861666 ⤷  Get Started Free SPC 038/2006 Ireland ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.